Position | Company | Period |
---|---|---|
Independent Director | Senseonics Holdings Inc | 1. Dezember 2015 - 30. Juni 2019 |
Independent Chairman of the Board | Clovis Oncology Inc | 20. April 2009 - 5. Juni 2019 |
Independent Chairman of the Board | GlycoMimetics Inc | 1. Januar 2017 - 17. Mai 2019 |
Chairman of the Board | GlycoMimetics Inc | None - |
Independent Chairman of the Board | Supernus Pharmaceuticals Inc | 1. Januar 2005 - 10. August 2016 |
Director | Zosano Pharma Corp | 1. April 2012 - 22. Januar 2016 |
Independent Director | Amicus Therapeutics Inc | 1. August 2009 - 1. März 2015 |
Independent Director | Catalyst Biosciences Inc | 1. November 2002 - 31. Mai 2013 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2018-05-11 | 2018-05-10 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
5.533
-0.1%
17,8198.543 USD |
5.533 -0.1% | 17,81 | 98.543 USD | |
2018-05-11 | 2018-05-10 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
4.006
-0.1%
17,8171.347 USD |
4.006 -0.1% | 17,81 | 71.347 USD | |
2015-11-18 | 2015-11-16 |
GlycoMimetics Inc
(GLYC)
|
V Verkauf |
452
-0.0%
6,913.123 USD |
452 -0.0% | 6,91 | 3.123 USD | |
2014-01-15 | 2014-01-15 |
GlycoMimetics Inc
(GLYC)
|
K Kauf |
512.500
+14.3%
8,004.100.000 USD |
512.500 +14.3% | 8,00 | 4.100.000 USD | |
2014-01-15 | 2014-01-15 |
GlycoMimetics Inc
(GLYC)
|
K Kauf |
487.500
+12.2%
8,003.900.000 USD |
487.500 +12.2% | 8,00 | 3.900.000 USD |